Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03315065 · ClinicalTrials.gov registry record · Early Phase 1
19F Thoracic Radiotherapy for Lung Cancer
A Early Phase 1 study, sponsored by Hal C Charles.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
NCT03315065 is a Early Phase 1 study that has completed, run by Hal C Charles. The registered enrollment target is 6 participants.
The verdict
NCT03315065, a Early Phase 1 study, has completed, sponsored by Hal C Charles.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The goal of this study is to determine the feasibility and efficiency of incorporating 19F MR functional lung imaging into the routine assessment of lung cancer patients prior to thoracic radiotherapy.
Interventions
- DRUG Perfluorinated Gas/Oxygen Mixture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-02-16 |
| Est. Completion | 2019-06-25 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03315065
The ClinicalTrials.gov registry entry for NCT03315065 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hal C Charles, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Perfluorinated Gas/Oxygen Mixture is the first listed.
NCT03315065 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03315065 about?
NCT03315065 is a clinical study titled "19F Thoracic Radiotherapy for Lung Cancer". The goal of this study is to determine the feasibility and efficiency of incorporating 19F MR functional lung imaging into the routine assessment of lung cancer patients prior to thoracic radiotherapy.
What is the current status of trial NCT03315065?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2018-02-16. Estimated completion is 2019-06-25.
What interventions are being tested in trial NCT03315065?
The interventions under investigation include: Perfluorinated Gas/Oxygen Mixture (DRUG).
Who is sponsoring clinical trial NCT03315065?
This trial is sponsored by Hal C Charles, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.